8.2 Measuring costs and benefits

Cost-benefit analysis is crucial for evaluating interventions. It involves identifying direct and indirect costs, as well as tangible and intangible benefits. Measuring these factors can be tricky, especially for non-market goods and long-term impacts.

Various methods help quantify costs and benefits, from market-based approaches to survey techniques. Discounting future values and addressing challenges like measurement bias and ethical considerations are key to conducting thorough cost-benefit analyses in impact evaluation.

Costs and Benefits of Interventions

Types of Direct and Indirect Costs

Top images from around the web for Types of Direct and Indirect Costs

• 

  Cost Analysis – Massive Open Online Course (MOOC) on MOOCs: Course Evaluation View original

  Is this image relevant?

• 

  Nonprofit Overhead Costs: Breaking the Vicious Cycle of Misleading Reporting, Unrealistic ... View original

  Is this image relevant?

• 

  Allocate Indirect Costs | Bridgespan View original

  Is this image relevant?

• 

  Cost Analysis – Massive Open Online Course (MOOC) on MOOCs: Course Evaluation View original

  Is this image relevant?

• 

  Nonprofit Overhead Costs: Breaking the Vicious Cycle of Misleading Reporting, Unrealistic ... View original

  Is this image relevant?

1 of 3

Top images from around the web for Types of Direct and Indirect Costs

• 

  Cost Analysis – Massive Open Online Course (MOOC) on MOOCs: Course Evaluation View original

  Is this image relevant?

• 

  Nonprofit Overhead Costs: Breaking the Vicious Cycle of Misleading Reporting, Unrealistic ... View original

  Is this image relevant?

• 

  Allocate Indirect Costs | Bridgespan View original

  Is this image relevant?

• 

  Cost Analysis – Massive Open Online Course (MOOC) on MOOCs: Course Evaluation View original

  Is this image relevant?

• 

  Nonprofit Overhead Costs: Breaking the Vicious Cycle of Misleading Reporting, Unrealistic ... View original

  Is this image relevant?

1 of 3

• Direct costs stem from implementing an intervention or policy (personnel, equipment, materials)
• Indirect costs result secondarily from the intervention (administrative overhead, opportunity costs)
• Opportunity costs represent value of foregone alternatives when allocating resources
• Time-dependent costs vary over intervention duration (initial investments, recurring expenses)

Categories of Benefits and Externalities

• Tangible benefits offer quantifiable positive outcomes measurable in monetary terms (increased revenue, reduced expenses)
• Intangible benefits provide positive outcomes difficult to quantify or monetize (improved quality of life, enhanced social cohesion)
• Externalities create unintended costs or benefits affecting uninvolved third parties
  • Positive externalities (improved public health from vaccination programs)
  • Negative externalities (environmental pollution from industrial activities)

Quantifying and Monetizing Costs and Benefits

Market-Based Valuation Methods

• Market pricing assigns monetary values using existing market values for intervention-related goods and services
• Revealed preference methods infer non-market goods value based on observed consumer behavior in related markets
  • Travel cost method estimates recreational site value by analyzing visitor travel expenses
  • Hedonic pricing determines environmental amenities' value through property price differences
• Shadow pricing estimates true economic value when market prices distort or unavailable
  • Adjusts for market imperfections, taxes, or subsidies
  • Used in contexts with limited market data or government intervention

Survey-Based and Health-Related Valuation Techniques

• Stated preference methods use surveys to determine willingness to pay for non-market goods or services
  • Contingent valuation asks respondents to directly state their willingness to pay
  • Choice experiments present respondents with hypothetical scenarios to infer preferences
• Human capital approach values health outcomes by estimating economic productivity changes due to health status alterations
• Cost-of-illness studies estimate economic burden of health conditions
  • Direct medical costs (hospitalization, medication)
  • Indirect costs (lost productivity, caregiver time)

Transferring and Adapting Existing Valuations

• Benefit transfer adapts existing valuation estimates from similar contexts to evaluated intervention or policy
  • Unit value transfers apply fixed values from study sites to policy sites
  • Function transfers use statistical relationships from study sites to estimate policy site values

Discounting in Cost-Benefit Analysis

Fundamental Concepts and Calculations

• Discounting converts future costs and benefits to present value, reflecting time preference for money and resources
• Discount rate represents rate at which future values convert to present values
  • Based on factors like opportunity cost of capital or social time preference
• Net present value (NPV) subtracts discounted costs from discounted benefits
  • NPV formula: $NPV = \sum_{t=0}^{T} \frac{B_t - C_t}{(1+r)^t}$
    • Where $B_t$ = benefits in year t, $C_t$ = costs in year t, r = discount rate, T = time horizon
• Internal rate of return (IRR) identifies discount rate where NPV equals zero
  • IRR formula: $0 = \sum_{t=0}^{T} \frac{B_t - C_t}{(1+IRR)^t}$

Advanced Discounting Considerations

• Sensitivity analysis varies discount rates to assess impact on cost-benefit analysis results
• Social discount rates apply to public sector projects, often lower than private sector rates
  • Reflect societal preferences for long-term outcomes
  • Consider intergenerational equity and sustainability
• Hyperbolic discounting models account for individual tendency to weigh near-term outcomes more heavily
  • Discount rate decreases over time
  • Formula: $PV = \frac{FV}{(1 + k \times t)^{\frac{\alpha}{k}}}$
    • Where PV = present value, FV = future value, k and α = parameters determining degree of hyperbolic discounting, t = time

Challenges in Measuring Costs and Benefits

Methodological and Data-Related Issues

• Measurement bias occurs when estimating costs and benefits, especially for intangible outcomes
  • Recall bias in surveys
  • Selection bias in sampling
• Data limitations affect accuracy and comprehensiveness of cost-benefit analyses
  • Incomplete or unreliable information
  • Lack of longitudinal data for long-term impacts
• Valuation challenges arise when monetizing non-market goods or services
  • Potential underestimation or overestimation of true value
  • Difficulty in capturing cultural or spiritual values

Ethical and Long-Term Considerations

• Distributional effects may not adequately reflect in aggregate cost-benefit measures
  • Mask important equity considerations across different socioeconomic groups
  • Fail to capture uneven distribution of costs and benefits
• Long-term impacts and uncertainties challenge accurate prediction and quantification
  • Climate change effects on future generations
  • Technological advancements altering intervention effectiveness
• Ethical considerations emerge when monetizing certain outcomes
  • Value of statistical life in health interventions
  • Biodiversity loss in environmental projects
• Strategic behavior in stated preference methods can bias willingness to pay estimates
  • Respondents may overstate or understate values to influence policy decisions
  • Free-riding behavior in public goods valuation